Navigenics, Inc., a prominent player in the personalised genomics industry, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in providing genetic testing and analysis services, focusing on health and wellness insights derived from DNA. Navigenics offers a range of core products, including comprehensive genetic testing that empowers individuals to make informed health decisions. Their unique approach combines advanced genomic technology with personalised health reports, setting them apart in a competitive market. With a commitment to innovation, Navigenics has achieved significant milestones, including partnerships with healthcare providers and research institutions. This positions the company as a trusted resource in the evolving landscape of personalised medicine, catering to a growing demand for genetic insights in health management.
How does Navigenics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Navigenics, Inc.'s score of 94 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Navigenics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is part of a corporate family that includes Thermo Fisher Scientific Inc., from which it inherits emissions data and climate commitments. As a merged entity, Navigenics aligns its climate initiatives with those of Thermo Fisher Scientific Inc., which has established various sustainability targets. However, specific reduction targets or achievements for Navigenics are not detailed in the available information. The company is involved in broader climate initiatives, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are sourced from Thermo Fisher Scientific Inc. at a cascade level of 5. This indicates a commitment to aligning with industry standards for emissions reduction, although specific targets for Navigenics are not disclosed. In summary, while Navigenics, Inc. does not provide direct emissions data or specific reduction targets, it is integrated into the climate strategies of its parent company, Thermo Fisher Scientific Inc., reflecting a commitment to sustainability within its operational framework.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 
Navigenics, Inc.'s Scope 3 emissions, which decreased by 13% last year and decreased by approximately 15% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Navigenics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.